UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE

This adverse event was reported 119 times

These drugs are most commonly taken by patients reporting UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE:

# Drug Count
0 METHOTREXATE SODIUM 43
1 METHOTREXATE 39
2 DICLOFENAC SODIUM 33
3 DICLOFENAC 32
4 PREGABALIN 32
5 NAPROXEN 31
6 NAPROXEN SODIUM 31
7 LEFLUNOMIDE 29
8 HYDROXYCHLOROQUINE SULFATE 12
9 FOLIC ACID 10
See all common drugs associated with UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE

UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRACAINE 1 0.0025
1 CHROMIC CHLORIDE 2 0.0023
2 ETHACRYNIC ACID 1 0.0018
3 OSILODROSTAT 2 0.0009
4 LOTEPREDNOL ETABONATE 4 0.0007
5 ALENDRONATE SODIUM AND CHOLECALCIFEROL 2 0.0007
6 ESLICARBAZEPINE ACETATE 2 0.0006
7 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 1 0.0005
8 CLORAZEPATE DIPOTASSIUM 1 0.0005
9 IRON SUCROSE 4 0.0004
See all drugs enriched for association with UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE